EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 20 March 2025

Cancer care 2025: an overview of cancer outcomes data across Europe

Read the full report

Despite data showing that cancer is on track to become the leading cause of death in the EU by 2035, encouraging signs are emerging.

The first in depth look at cancer comparisons since 2019 by The Swedish Institute for Health Economics’ (IHE) new report shows that the number of cancer deaths is stabilising, with 12 EU countries seeing a decline in deaths (per 100,000), signalling a turning point in the fight against the disease. Overall, cancer deaths in Europe have stabilized at around 1.3-1.4 million annually since 2008.

The research shows that cancer survival rates have improved across Europe, but disparities between countries – as well as types of cancers – remain.

Harnessing RWE to transform healthcare decision-making in Europe
17 March 2025

EFPIA vision on the role and use of RWE in decision-making Read more

Discover MEPs' views on how to create a healthier, more competitive Europe

Interview with MEP Nicolas Gonzalez Casares

In this brief interview, MEP Nicolas Gonzalez Casares talks about the steps we can take to improve Europe's health... Read more

Interview with MEP Tomislav Sokol

Watch this short interview with MEP Tomislav Sokol where he outlines his vision for ensuring health remains a top... Read more

Events

Lp(a) Global Summit 2025
24 March 2025 (Brussels, Belgium)

The Lp(a) Global Summit 2025 is an exclusive, high-level event dedicated to shaping the future of cardiovascular health... Read more

Unlocking efficiency through reliance: Navigating the EMA post-authorization framework
03 April 2025 (Virtual event)

Register now to join this webinar. Read more

Vaccines & the EU HTA regulation: Why, what and how?
15 April 2025 (Virtual event)

With the EU HTA regulation now in force (January 2025), this session will explore the critical need to account for vaccines... Read more

International conference on protein stability – The gap between industry and administration...
13 May 2025 (Södertälje Science Park, Sweden)

The objective of this symposium/conference is to create an arena for discussions on the recent research and industrial... Read more

What we are reading

Europe has a platform for driving more flexible clinical trials: It’s time to use it
On 13 March 2025 (Pharma Boardroom)

To address the European Union’s drop in global share of clinical trials over the past decade, stakeholders are working... Read more

New clinical trial map launched in the EU
On 03 March 2025 (European Medicines Agency)

A new clinical trial map is now accessible from the public website of the Clinical Trials Information System (CTIS).... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu